Quarterly
Annual
| Unit: USD | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net revenue | 116,193,000 | 114,565,000 | 91,409,000 | 109,735,000 | 93,100,000 | 92,894,000 | 70,650,000 | 85,918,000 | 70,384,000 | 68,980,000 | 48,420,000 | 53,135,000 | 46,913,000 | 34,783,000 | 35,243,000 | 15,213,000 | 26,296,000 | 9,946,000 | 1,309,000 | 1,488,000 | 1,077,000 | 494,000 | 201,000 | ||
cost of goods sold | 26,542,000 | 25,422,000 | 22,156,000 | 26,975,000 | 23,996,000 | 22,704,000 | 18,150,000 | 22,951,000 | 19,124,000 | 18,784,000 | 15,178,000 | 17,744,000 | 15,719,000 | 17,135,000 | 13,974,000 | 12,652,000 | 13,434,000 | 8,463,000 | 9,895,000 | 4,538,000 | 632,000 | 772,000 | 548,000 | 245,000 | 106,000 |
gross profit | 89,651,000 | 89,143,000 | 69,253,000 | 82,760,000 | 69,104,000 | 70,190,000 | 52,500,000 | 62,967,000 | 51,260,000 | 50,196,000 | 33,242,000 | 35,391,000 | 31,194,000 | 28,734,000 | 20,399,000 | 22,131,000 | 21,809,000 | 6,750,000 | 16,401,000 | 5,408,000 | 677,000 | 716,000 | 529,000 | 249,000 | 95,000 |
yoy | 29.73% | 27.00% | 31.91% | 31.43% | 34.81% | 39.83% | 57.93% | 77.92% | 64.33% | 74.69% | 62.96% | 59.92% | 43.03% | 325.69% | 24.38% | 309.23% | 3121.42% | 842.74% | 3000.38% | 2071.89% | 612.63% | ||||
qoq | 0.57% | 28.72% | -16.32% | 19.76% | -1.55% | 33.70% | -16.62% | 22.84% | 2.12% | 51.00% | -6.07% | 13.45% | 8.56% | 40.86% | -7.83% | 1.48% | 223.10% | -58.84% | 203.27% | 698.82% | -5.45% | 35.35% | 112.45% | 162.11% | |
gross margin % | 62.64% | 59.35% | |||||||||||||||||||||||
operating expenses | |||||||||||||||||||||||||
research and development | 13,491,000 | 12,792,000 | 11,056,000 | 9,714,000 | 8,167,000 | 8,949,000 | 8,056,000 | 8,103,000 | 7,936,000 | 7,135,000 | 11,236,000 | 10,182,000 | 8,648,000 | 9,098,000 | 9,369,000 | 8,140,000 | 7,748,000 | 6,398,000 | 6,884,000 | 6,233,000 | 4,855,000 | 4,874,000 | 4,219,000 | 4,783,000 | 3,898,000 |
general and administrative | 23,761,000 | 16,327,000 | 15,104,000 | 11,095,000 | 11,778,000 | 10,713,000 | 12,168,000 | 10,264,000 | 9,389,000 | 10,572,000 | 10,013,000 | 9,404,000 | 8,720,000 | 8,035,000 | 6,626,000 | 6,588,000 | 5,773,000 | 5,537,000 | 7,653,000 | 5,537,000 | 5,162,000 | 4,362,000 | 4,015,000 | 3,501,000 | 2,790,000 |
sales and marketing | 52,972,000 | 51,444,000 | 56,191,000 | 55,094,000 | 47,544,000 | 44,270,000 | 42,654,000 | 43,824,000 | 39,751,000 | 39,381,000 | 33,063,000 | 31,338,000 | 28,112,000 | 25,411,000 | 20,928,000 | 18,284,000 | 17,057,000 | 14,220,000 | 16,569,000 | 16,301,000 | 15,707,000 | 10,750,000 | 5,914,000 | 1,416,000 | 949,000 |
amortization of intangible assets | 2,221,000 | 2,247,000 | 2,254,000 | 2,261,000 | 2,302,000 | 2,279,000 | 2,222,000 | 2,271,000 | 2,317,000 | 2,332,000 | 2,463,000 | 2,147,000 | 2,216,000 | 2,200,000 | 678,000 | ||||||||||
acquisition-related costs | 3,474,000 | 2,652,000 | 3,827,000 | 3,530,000 | 602,000 | 1,766,000 | 2,114,000 | 8,242,000 | 12,205,000 | 4,414,000 | |||||||||||||||
acquired in-process research & development | 15,447,000 | ||||||||||||||||||||||||
total operating expenses | 95,919,000 | 85,462,000 | 88,432,000 | 81,694,000 | 69,791,000 | 82,260,000 | 66,866,000 | 66,576,000 | 67,635,000 | 71,625,000 | 56,775,000 | 53,071,000 | 47,696,000 | 44,744,000 | 42,015,000 | 33,012,000 | 30,578,000 | 26,155,000 | 31,106,000 | 28,071,000 | 25,724,000 | 19,986,000 | 14,148,000 | 9,700,000 | 7,637,000 |
income from operations | -6,268,000 | 3,681,000 | -19,179,000 | 1,066,000 | -687,000 | -12,070,000 | -14,366,000 | -3,609,000 | -16,375,000 | -21,429,000 | -23,533,000 | -17,680,000 | -16,502,000 | -16,010,000 | -21,616,000 | -10,881,000 | -8,769,000 | -19,405,000 | -14,705,000 | -22,663,000 | -25,047,000 | -19,270,000 | -13,619,000 | -9,451,000 | -7,542,000 |
yoy | 812.37% | -130.50% | 33.50% | -129.54% | -95.80% | -43.67% | -38.95% | -79.59% | -0.77% | 33.85% | 8.87% | 62.49% | 88.19% | -17.50% | 47.00% | -51.99% | -64.99% | 0.70% | 7.97% | 139.79% | 232.10% | ||||
qoq | -270.28% | -119.19% | -1899.16% | -255.17% | -94.31% | -15.98% | 298.06% | -77.96% | -23.58% | -8.94% | 33.11% | 7.14% | 3.07% | -25.93% | 98.66% | 24.08% | -54.81% | 31.96% | -35.11% | -9.52% | 29.98% | 41.49% | 44.10% | 25.31% | |
operating margin % | -34.90% | -62.89% | |||||||||||||||||||||||
other income | 4,712,000 | 4,670,000 | 3,914,000 | 4,390,000 | 4,188,000 | 4,424,000 | 4,311,000 | 3,752,000 | -397,000 | -479,000 | -246,000 | 27,000 | -220,000 | -5,842,000 | -1,442,000 | -467,000 | -399,000 | -378,000 | 90,000 | -88,000 | 41,000 | 210,000 | 502,000 | 234,000 | -196,000 |
interest and other income | 4,704,000 | 4,702,000 | 3,973,000 | 4,541,000 | 4,271,000 | 4,250,000 | 3,628,000 | 8,159,000 | -1,898,000 | -839,000 | -289,000 | 102,000 | -229,000 | -5,849,000 | -1,450,000 | -445,000 | -434,000 | -443,000 | -552,000 | -562,000 | -586,000 | -629,000 | -532,000 | ||
income before income tax (benefit) expense | -1,556,000 | 143,000 | -16,772,000 | -21,908,000 | -23,058,000 | ||||||||||||||||||||
income tax (benefit) expense | -1,535,000 | -522,000 | -520,000 | -465,000 | -555,000 | ||||||||||||||||||||
net income | -21,000 | 6,899,000 | -19,112,000 | 6,574,000 | 3,928,000 | -7,342,000 | -9,248,000 | 665,000 | -16,252,000 | -21,443,000 | -22,668,000 | -15,166,000 | -17,250,000 | -25,148,000 | -22,503,000 | -11,348,000 | -9,168,000 | -19,783,000 | -14,616,000 | -22,751,000 | -25,006,000 | -19,061,000 | -13,117,000 | -9,665,000 | -7,566,000 |
yoy | -100.53% | -193.97% | 106.66% | 888.57% | -124.17% | -65.76% | -59.20% | -104.38% | -5.79% | -14.73% | 0.73% | 33.64% | 88.15% | 27.12% | 53.96% | -50.12% | -63.34% | 3.79% | 11.43% | 135.40% | 230.50% | ||||
qoq | -100.30% | -136.10% | -390.72% | 67.36% | -153.50% | -20.61% | -1490.68% | -104.09% | -24.21% | -5.40% | 49.47% | -12.08% | -31.41% | 11.75% | 98.30% | 23.78% | -53.66% | 35.35% | -35.76% | -9.02% | 31.19% | 45.32% | 35.72% | 27.74% | |
net income margin % | -54.83% | -65.47% | |||||||||||||||||||||||
foreign currency translation adjustment | 10,438,000 | 466,000 | -1,152,000 | 8,644,000 | -6,185,000 | 3,750,000 | 3,071,000 | 11,038,000 | -12,057,000 | -12,648,000 | -4,920,000 | 352,000 | -5,138,000 | 859,000 | -2,202,000 | 183,000 | 99,000 | -108,000 | -177,000 | 153,000 | -112,000 | -43,000 | -10,000 | -10,000 | -1,000 |
comprehensive income | 10,417,000 | 7,365,000 | |||||||||||||||||||||||
net income per share | 0 | 0.14 | -0.38 | 0.14 | 0.08 | -0.15 | -0.19 | 0.03 | -0.34 | -0.47 | -0.5 | -0.33 | -0.38 | -0.59 | -0.57 | -0.28 | -0.24 | -0.54 | -0.43 | -0.75 | -0.89 | -0.68 | -0.47 | 3.46 | -2.67 |
weighted-average shares used for eps calculation | 51,088,073 | 50,010,380 | 50,928,171 | 49,081,470 | 49,244,981 | 49,088,373 | 48,579,084 | 46,684,478 | 47,208,192 | 45,311,001 | 45,139,038 | 43,072,298 | 44,848,023 | 42,788,678 | 39,613,964 | 36,981,335 | 38,830,924 | 36,440,846 | 33,637,646 | 28,567,302 | 28,098,564 | 27,945,393 | 27,828,201 | 6,997,777 | 2,830,591 |
income before income tax benefit | 8,351,000 | -15,265,000 | -3,550,000 | 3,501,000 | -7,646,000 | -10,055,000 | -23,779,000 | ||||||||||||||||||
income tax benefit | 1,452,000 | 3,847,000 | -384,500 | -427,000 | -304,000 | -807,000 | -1,111,000 | ||||||||||||||||||
comprehensive loss | -20,264,000 | -3,006,500 | -2,257,000 | -3,592,000 | -6,177,000 | 11,703,000 | -28,309,000 | -34,091,000 | -27,588,000 | -14,814,000 | -22,388,000 | -24,289,000 | -24,705,000 | -11,165,000 | -9,069,000 | -19,891,000 | -14,793,000 | -22,598,000 | -25,118,000 | -19,104,000 | -13,127,000 | -9,675,000 | -7,567,000 | ||
interest income | 476,000 | 1,501,000 | 360,000 | 43,000 | 16,000 | 9,000 | 7,000 | 8,000 | 19,000 | 35,000 | 65,000 | 642,000 | 474,000 | 627,000 | 839,000 | 1,034,000 | 550,000 | 172,000 | |||||||
income before income tax expense | -17,653,000 | -16,722,000 | -21,852,000 | -11,348,000 | -9,168,000 | -19,783,000 | -14,615,000 | -22,751,000 | -25,006,000 | -19,060,000 | -13,117,000 | -9,665,000 | -7,566,000 | ||||||||||||
income tax expense | -2,487,000 | 528,000 | 3,296,000 | 1,000 | 1,000 | ||||||||||||||||||||
sacral neuromodulation net revenue | 40,194,000 | 32,903,000 | |||||||||||||||||||||||
bulkamid net revenue | 5,675,000 | 1,470,000 | |||||||||||||||||||||||
total net revenue | 45,869,000 | 34,373,000 | |||||||||||||||||||||||
yoy | |||||||||||||||||||||||||
qoq | 33.44% |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
